The Value of BCG and TNF in Autoimmunity

Nonfiction, Health & Well Being, Medical, Medical Science, Immunology, Science & Nature, Science
Cover of the book The Value of BCG and TNF in Autoimmunity by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780128004616
Publisher: Elsevier Science Publication: March 13, 2014
Imprint: Academic Press Language: English
Author:
ISBN: 9780128004616
Publisher: Elsevier Science
Publication: March 13, 2014
Imprint: Academic Press
Language: English

The Value of BCG and TNF in Autoimmunity provides an overview of current research and thinking related to tumor necrosis factor (TNF) induction and the use of the bacillus Calmette-Guérin (BCG) vaccine as potential treatment approaches to diverse forms of autoimmunity. BCG, commonly known as an anti-tuberculosis vaccine, is being explored in worldwide clinical trials as an approach to the treatment of certain forms of autoimmunity. The scope of research behind this therapeutic approach spans from the basic science of TNF signaling to research in diverse autoimmune disciplines, such as type 1 diabetes and multiple sclerosis.

Overall, the book focuses on the lessons that can be learned from the researchers' individual experiences and data, and provides a rationale for bringing the inexpensive, generic BCG vaccine to the forefront of clinical trials in different forms of autoimmunity.

  • Editor awarded 2005: Oprah Achievement Award," Top Health Breakthrough by a Female Scientist"
  • Brings into one resource the international scientific literature on a unique way to treat autoimmunity
  • Provides a different perspective on treatment approaches for certain autoimmune conditions
  • Discusses TNF induction, rather than anti-TNF, as a therapeutic pathway for autoimmunity treatment
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The Value of BCG and TNF in Autoimmunity provides an overview of current research and thinking related to tumor necrosis factor (TNF) induction and the use of the bacillus Calmette-Guérin (BCG) vaccine as potential treatment approaches to diverse forms of autoimmunity. BCG, commonly known as an anti-tuberculosis vaccine, is being explored in worldwide clinical trials as an approach to the treatment of certain forms of autoimmunity. The scope of research behind this therapeutic approach spans from the basic science of TNF signaling to research in diverse autoimmune disciplines, such as type 1 diabetes and multiple sclerosis.

Overall, the book focuses on the lessons that can be learned from the researchers' individual experiences and data, and provides a rationale for bringing the inexpensive, generic BCG vaccine to the forefront of clinical trials in different forms of autoimmunity.

More books from Elsevier Science

Cover of the book Fetal and Neonatal Disorders by
Cover of the book Health Education and the Media II by
Cover of the book Sweet Potato by
Cover of the book Clusterin, Part B by
Cover of the book The Ore Minerals Under the Microscope by
Cover of the book Kaufman’s Atlas of Mouse Development Supplement by
Cover of the book Power System Energy Storage Technologies by
Cover of the book Optoelectronics Circuits Manual by
Cover of the book Metal and Ceramic Based Composites by
Cover of the book Exact Statistical Inference for Categorical Data by
Cover of the book Fiber Bragg Gratings by
Cover of the book Pyridines: From Lab to Production by
Cover of the book Machine Learning and Medical Imaging by
Cover of the book Underwriting Services and the New Issues Market by
Cover of the book Ice Microdynamics by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy